|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2007-12-6
|
|
pubmed:abstractText |
Recent studies in selected human tumors have demonstrated reduced expression of HRK with hypermethylation. Because no similar study has been performed specifically in prostatic lesions, we examined whether the methylation status of HRK is altered in prostate cancers.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0270-4137
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2007 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
68
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
105-13
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:18008329-Apoptosis,
pubmed-meshheading:18008329-Apoptosis Regulatory Proteins,
pubmed-meshheading:18008329-DNA Methylation,
pubmed-meshheading:18008329-Exons,
pubmed-meshheading:18008329-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:18008329-Humans,
pubmed-meshheading:18008329-Loss of Heterozygosity,
pubmed-meshheading:18008329-Male,
pubmed-meshheading:18008329-Promoter Regions, Genetic,
pubmed-meshheading:18008329-Prostatic Neoplasms,
pubmed-meshheading:18008329-RNA, Messenger,
pubmed-meshheading:18008329-Tumor Suppressor Protein p53
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
HRK inactivation associated with promoter methylation and LOH in prostate cancer.
|
|
pubmed:affiliation |
Department of Pathology, Nara Medical University School of Medicine, Nara, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
